| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN | 11 |
| 1 | INFLIXIMAB | 8 |
| 2 | ADALIMUMAB | 7 |
| 3 | ASPIRIN | 7 |
| 4 | PREDNISONE | 7 |
| 5 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 6 |
| 6 | ASPIRIN 325 MG | 6 |
| 7 | ASPIRIN 81 MG | 6 |
| 8 | MESALAMINE | 6 |
| 9 | ACETAMINOPHEN 500MG | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 5 | 0.0015 |
| 1 | AZATHIOPRINE SODIUM | 3 | 0.0012 |
| 2 | PSYLLIUM HUSK | 1 | 0.0007 |
| 3 | SENNOSIDES A AND B | 1 | 0.0006 |
| 4 | DHEA (DEHYDROEPIANDROSTERONE) | 1 | 0.0005 |
| 5 | PRAZOSIN | 3 | 0.0005 |
| 6 | TOPOTECAN HYDROCHLORIDE | 1 | 0.0004 |
| 7 | ADALIMUMAB-AFZB | 1 | 0.0004 |
| 8 | DEFERIPRONE | 1 | 0.0003 |
| 9 | SCOPOLAMINE | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 18 |
| 1 | Corticosteroid [EPC] | 11 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 10 |
| 3 | Expectorant [EPC] | 7 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 7 |
| 5 | Aminosalicylate [EPC] | 6 |
| 6 | Interleukin-23 Antagonist [EPC] | 6 |
| 7 | Purine Antimetabolite [EPC] | 6 |
| 8 | Integrin Receptor Antagonist [EPC] | 5 |
| 9 | Kinase Inhibitor [EPC] | 5 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 1 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 2 | Cannabinoid [EPC] | 1 | 0.0001 |
| 3 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 4 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 5 | Calcitonin Gene-related Peptide Antagonist [EPC] | 1 | 0.0001 |
| 6 | Antimalarial [EPC] | 1 | 0.0001 |
| 7 | Antiprotozoal [EPC] | 1 | 0.0001 |
| 8 | Bile Acid Sequestrant [EPC] | 1 | 0.0001 |
| 9 | GLP-2 Analog [EPC] | 1 | 0.0001 |